Skip to main content
. Author manuscript; available in PMC: 2015 Dec 28.
Published in final edited form as: J Control Release. 2014 Oct 24;0:272–286. doi: 10.1016/j.jconrel.2014.10.016

Fig. 11.

Fig. 11

In vivo (A) and ex vivo (B) NIRF optical images of PC-3 tumor-bearing nude mice administered intravenously with DiD-loaded PEG5K-Fmoc-VE2 nanoparticles. Tumors and major organs were excised for ex vivo imaging at 96 h post-injection and the quantitated DiD fluorescence intensity from different organs were presented (C).